Stockscreener 앱 받기
21.86
4.08%
-0.985
Ultragenyx Pharmaceutical Inc 주식(RARE)의 최신 뉴스
LEVI & KORSINSKY, LLP: CEO AND CMO NAMED AS CONTROL PERSON DEFENDANTS IN ULTRAGENYX PHARMACEUTICAL SECURITIES ACTION - Finviz
RARE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 – Company AnnouncementFT.com - Financial Times
Sands Capital Management LLC Cuts Stock Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Insider Sell: Karah Parschauer Sells Shares of Ultragenyx Pharma - GuruFocus
RARE Investors Have Opportunity to Lead Ultragenyx - GlobeNewswire
Investors who lost money on Ultragenyx Pharmaceutical Inc.(RARE) should contact The Gross Law Firm about pending Class ActionRARE - PR Newswire
Ultragenyx EVP Pinion sells $228k in shares - Investing.com Nigeria
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Biopharma Brass Hid Drug Trial Risks, Derivative Suit Says - Law360
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit - Financial Times
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ultragenyx - GlobeNewswire
Levi & Korsinsky, LLP: Institutional Investor Notice --- Ultragenyx Pharmaceutical Lead Plaintiff Opportunity - GlobeNewswire
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Up 5.6%Still a Buy? - MarketBeat
Portnoy Law Firm Announces Class Action on Behalf of Ultragenyx Pharmaceutical, Inc. Investors - GlobeNewswire
FinancialContentUltragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit Seeks Recovery for Investors; April 6, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Richtech Robotics Inc. (RR), Ultragenyx Pharmaceutical Inc. (RARE), and Mereo BioPharma Group plc (MREO) Announced by Holzer & Holzer, LLC - marketscreener.com
CLASS ACTION INVESTOR ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ultragenyx and Mereo BioPharma and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
RARE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages RARE Investors with Losses to Contact the Firm - Financial Times
Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - GlobeNewswire Inc.
Analysis Recap: Can Ultragenyx Pharmaceutical Inc. (UP0) stock stage a strong rebound this quarter2025 Trade Ideas & Community Verified Trade Alerts - Naître et grandir
Ultragenyx Pharmaceutical Inc. $RARE Stock Position Increased by Blue Owl Capital Holdings LP - MarketBeat
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc.RARE - StreetInsider
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Contact The Gross Law Firm by April 6, 2026 Deadline to Join Class Action Against Ultragenyx ... - Bluefield Daily Telegraph
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Ultragenyx Pharmaceutical Inc. (RARE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - FinancialContent
RARE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Investors of Securities Class Action Deadline on April 6, 2026 – Company Announcement - Financial Times
GW&K Investment Management LLC Buys 668,881 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitRGRD Law - Sahm
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming DeadlinesRARE - PR Newswire
Skeletal Dysplasia Market - GlobeNewswire Inc.
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline - NewMediaWire
Robbins LLP Urges RARE Stockholders to Contact the Firm for - GlobeNewswire
UPCOMING DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Securities Fraud Class Action – April ... - Bluefield Daily Telegraph
UPCOMING DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) - GlobeNewswire
Ultragenyx Pharmaceutical Inc. $RARE Shares Bought by Rafferty Asset Management LLC - MarketBeat
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 - GlobeNewswire
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
Ultragenyx Pharmaceutical (NASDAQ:RARE) Insider Sells $228,661.20 in Stock - MarketBeat
Howard Horn Sells 1,635 Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock - MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) EVP Sells $185,478.00 in Stock - MarketBeat
Theodore Alan Huizenga Sells 1,632 Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock - MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) EVP Eric Crombez Sells 7,029 Shares - MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) EVP Sells 10,539 Shares - MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Sells $190,884.30 in Stock - MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) CEO Sells 54,404 Shares - MarketBeat
Ultragenyx (RARE) CEO logs share award and tax-driven stock sale - Stock Titan
Ultragenyx (RARE) legal chief receives stock award, sells shares for taxes - Stock Titan
Ultragenyx (RARE) CAO disposes shares in RSU tax-related transactions - Stock Titan
Ultragenyx (RARE) CFO nets stock award and sells 10,044 shares - Stock Titan
Ultragenyx (RARE) CMO reports stock award and sale of common shares - Stock Titan
Ultragenyx (RARE) executive reports stock grant and tax share surrender - Stock Titan
User - The Chronicle-Journal
Shareholders that lost money on Ultragenyx Pharmaceutical Inc.(RARE) Urged to Join Class ActionContact The Gross Law Firm to Learn More - StreetInsider
Experts: Regulatory roadblocks stalling rare disease therapies - bioworld.com
Shareholders that lost money on Ultragenyx Pharmaceutical Inc.(R - GuruFocus
Howard Horn sells RARE shares (NASDAQ: RARE) in Form 144 disclosure - Stock Titan
Levi & Korsinsky, LLP: Section 10(b) and Rule 10b-5 Claims Filed Against Ultragenyx ... - Bluefield Daily Telegraph
Levi & Korsinsky, LLP: Section 10(b) and Rule 10b-5 Claims Filed Against Ultragenyx Pharmaceutical - marketscreener.com
NASDAQ: RARE Berger Montague Advises Ultragenyx Pharmaceutical Inc. (NASDAQ - marketscreener.com
Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit Seeks Recovery for Investors; April 6, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP - PR Newswire
Ultragenyx Pharmaceutical Inc. Investors with Substantial - GlobeNewswire
0.14%
0.34%
자본화:
|
볼륨(24시간):